However, the blood glucose level of patient MI2 with synchronous liver metastasis was still lower than standard range, which immediately increased and maintained within standard range after treatment of liver metastasis, implying the insulin secretion capability of liver metastasis (Figure 2). This evidence concerns the gene INS and metastasis.